Short answer
NOVANTA INC (NOVT) filed its Q4 2026 10-Q quarterly report on Nov 9, 2026 for the quarter ended Oct 2, 2026. Quarterly revenue was $305M (up 23.1% year over year) with net income of $2M.
Q4 2026 key financials · XBRL
- Revenue
- $305M
- +23.1% YoY · +14.7% QoQ
- Net income
- $2M
- −81.1% YoY · −83.9% QoQ
- Operating margin
- 4.6%
- Gross margin
- 44.5%
- EPS (diluted)
- $0.04
- −86.7% YoY · −87.1% QoQ
Source: XBRL data from the NOVANTA INC (NOVT) Q4 2026 10-Q on SEC EDGAR. USD.
NOVANTA INC Q4 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $305.0M, up $57.2M or 23.1% YoY, including $32.9M from the 2026 acquisition
- Total gross margin 44.5% vs 44.8% YoY, operating margin 4.6% vs 8.8% YoY
- Best segment Automation Enabling Technologies: revenue $145.4M, up 16.0%, operating margin 28.1% vs 21.8%
- Worst segment Medical Solutions margin: operating margin 6.0% vs 13.0%, gross margin 39.9% vs 43.0%
- Cash $149.2M vs $380.9M, operating cash flow $155.9M, acquisition investment $1,200.6M, 2026 capex outlook $30M to $40M
Risk Factors
- Newly added geopolitical risk: February 2026 U.S.-Israel-Iran conflict increased energy, freight and commodity costs
- Most material acquisition risk: Riverpoint Medical purchase for $1,200.6 million heightened integration and impairment exposure
- Regulatory risk: Chinese export-license restrictions delayed rare-earth material shipments and customer order fulfillment
- Operational risk: Limited or single-source components could cause missed shipments and permanent customer-order losses
- Financial risk: Total debt increased to $838.6 million as of October 2, 2026, raising variable-rate exposure
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other NOVANTA INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.